Same Indication

Ipilimumab vs Sacubitril-Valsartan

Ipilimumab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Sacubitril-Valsartan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Sacubitril-Valsartan — 11.5 hours.

Chemical Properties

Molecular Formula: Sacubitril-Valsartan — C24H29N2O5.

Molecular Weight: Sacubitril-Valsartan — 414.5010 g/mol.

Type: Ipilimumab — Antibody; Sacubitril-Valsartan — Small molecule.